Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicity.

Molecular techniques, such as cDNA microarrays, are being used to aid in the elucidation of the mechanisms of toxicity of a variety of compounds. In this study, we evaluate the molecular effects of furan in the rat liver. Sprague-Dawley rats were exposed to 4 or 40 mg/kg furan for up to 14 days. Furan induced an initial degenerative and necrotic phenotype that was followed by inflammation and fibrosis, consistent with previous observations for this compound. RNA was harvested from each lobe of the liver at several time points to observe whether lobe-specific gene expression effects occurred. Similar gene expression changes were observed in all lobes, however the magnitude of gene expression change was more pronounced in the right lobe. Finally, to help determine the correlation between gene expression changes and liver pathology, we applied traditional microarray visualization tools to the assessment of clinical chemistry and pathology parameters.

[1]  Lee Bennett,et al.  Gene expression analysis reveals chemical-specific profiles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Kerry Blanchard,et al.  Methapyrilene Toxicity: Anchorage of Pathologic Observations to Gene Expression Alterations , 2002, Toxicologic pathology.

[3]  D. Brenner,et al.  Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis , 2001, Seminars in liver disease.

[4]  R G Ulrich,et al.  Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.

[5]  D. Schuppan,et al.  The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis. , 1991, Journal of hepatology.

[6]  I. Jolliffe.  Principal Component Analysis , 2002 .

[7]  L. Elmore,et al.  Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan‐treated rats , 1992, Hepatology.

[8]  Developing toxicologically predictive gene sets using cDNA microarrays and Bayesian classification. , 2002, Methods in enzymology.

[9]  Y. N. Park,et al.  Increased expression of O-acetyl disialoganglioside synthase during rat liver fibrogenesis relates to stellate cell activation. , 2003, Biochemical and biophysical research communications.

[10]  L. Elmore,et al.  Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan. , 1991, Cancer research.

[11]  D. Schuppan,et al.  Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. , 1996, Journal of hepatology.

[12]  D. B. Kristensen,et al.  Characterization of a Stellate Cell Activation-associated Protein (STAP) with Peroxidase Activity Found in Rat Hepatic Stellate Cells* , 2001, The Journal of Biological Chemistry.

[13]  S. Thorgeirsson,et al.  Tissue inhibitor of metalloproteinases‐1 promotes liver fibrosis development in a transgenic mouse model , 2000, Hepatology.

[14]  Wen-bin Liu,et al.  Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid. , 2003, World journal of gastroenterology.

[15]  Lee Bennett,et al.  Prediction of compound signature using high density gene expression profiling. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  J. Iredale,et al.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.

[17]  L. Elmore,et al.  "Intestinal-type" of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan. , 1993, Cancer research.

[18]  Kate Johnson,et al.  MAPS: a microarray project system for gene expression experiment information and data validation , 2001, Bioinform..

[19]  J. Iredale,et al.  Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. , 1996, Gastroenterology.